La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Utah Medical Products Gestione
Gestione criteri di controllo 3/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Kevin Cornwell
Amministratore delegato
US$510.6k
Compenso totale
Percentuale dello stipendio del CEO | 29.8% |
Mandato del CEO | 31.7yrs |
Proprietà del CEO | 5.4% |
Durata media del management | Nessun dato |
Durata media del Consiglio di amministrazione | 27.6yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30
Aug 06Utah Medical Products: An Attractive, But Speculative, Prospect
Mar 22Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Feb 09Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Dec 13Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30
Nov 23Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30
Nov 03Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295
Aug 28Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?
Mar 04Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295
Feb 10A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)
Jan 11Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29
Aug 08Utah Medical Products declares $0.29 dividend
Aug 02Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M
Jul 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
May 14Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29
Feb 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
Feb 12Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital
Sep 28Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28
Aug 06Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation
May 01Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?
Mar 26Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital
Mar 02Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 11Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain
Jan 27Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?
Jan 13Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?
Dec 29Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?
Dec 15Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?
Nov 30Utah Medical Products declares $0.285 dividend
Nov 03Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Jun 30 2024 | n/a | n/a | US$16m |
Mar 31 2024 | n/a | n/a | US$16m |
Dec 31 2023 | US$511k | US$152k | US$17m |
Sep 30 2023 | n/a | n/a | US$17m |
Jun 30 2023 | n/a | n/a | US$17m |
Mar 31 2023 | n/a | n/a | US$17m |
Dec 31 2022 | US$452k | US$84k | US$16m |
Sep 30 2022 | n/a | n/a | US$16m |
Jun 30 2022 | n/a | n/a | US$16m |
Mar 31 2022 | n/a | n/a | US$15m |
Dec 31 2021 | US$494k | US$156k | US$15m |
Sep 30 2021 | n/a | n/a | US$14m |
Jun 30 2021 | n/a | n/a | US$13m |
Mar 31 2021 | n/a | n/a | US$11m |
Dec 31 2020 | US$327k | US$78k | US$11m |
Sep 30 2020 | n/a | n/a | US$12m |
Jun 30 2020 | n/a | n/a | US$13m |
Mar 31 2020 | n/a | n/a | US$15m |
Dec 31 2019 | US$474k | US$156k | US$15m |
Sep 30 2019 | n/a | n/a | US$14m |
Jun 30 2019 | n/a | n/a | US$17m |
Mar 31 2019 | n/a | n/a | US$18m |
Dec 31 2018 | US$501k | US$156k | US$19m |
Sep 30 2018 | n/a | n/a | US$13m |
Jun 30 2018 | n/a | n/a | US$10m |
Mar 31 2018 | n/a | n/a | US$9m |
Dec 31 2017 | US$501k | US$156k | US$9m |
Compensazione vs Mercato: La retribuzione totale di Kevin ($USD 510.57K ) è inferiore alla media delle aziende di dimensioni simili nel mercato US ($USD 1.54M ).
Compensazione vs guadagni: La retribuzione di Kevin è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Kevin Cornwell (77 yo)
31.7yrs
Mandato
US$510,570
Compensazione
Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah...
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Chairman | 31.6yrs | US$510.57k | 5.42% $ 12.9m | |
Independent Director | 26.6yrs | US$29.40k | 0.61% $ 1.5m | |
Independent Lead Director | 28.6yrs | US$37.80k | 0.14% $ 341.5k | |
Independent Director | 27.6yrs | US$29.40k | 0.14% $ 330.4k | |
Independent Director | 17.5yrs | US$29.40k | 0.38% $ 896.3k |
27.6yrs
Durata media
77yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di UTMD è composto da personale esperto e esperto (durata media dell'incarico 27.6 anni).